Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05270356 · ClinicalTrials.gov registry record
MINDS Imaging Ancillary Study
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 195
- Enrollment target
NCT05270356: Completed study, sponsored by University of Pittsburgh.
NCT05270356 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 195 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05270356 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 195 participants
- Enrollment target
Study Summary
This study is an ancillary study to the NHLBI-funded Pediatric Heart Network (PHN) "Multi-Institutional Neurocognitive Discovery Study" (MINDS) in Adult Congenital Heart Disease (ACHD). The MINDS-ACHD" study will recruit 500 complex CHD patients between18-30 years old. The investigators propose to quantitate multi-modal neuroimaging biomarkers (brain injury, structure and physiology) which are not only important components of brain and cognitive reserve but can be predictive of neurocognitive decline and early onset of dementia in the aging non-CHD population.
Primary Outcome
Vascular-related brain injury (cortical infarcts, hemosiderin lesions, and white matter hyperintensity)
Interventions
- OTHER MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 195 participants |
| Start Date | 2021-05-27 |
| Est. Completion | 2025-05-31 |
What the finished NCT05270356 record still lists
NCT05270356 is an observational study that tracks outcomes without assigning an intervention. The registered 195 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which MRI is the first listed.
NCT05270356 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05270356 about?
NCT05270356 is a clinical study titled "MINDS Imaging Ancillary Study". This study is an ancillary study to the NHLBI-funded Pediatric Heart Network (PHN) "Multi-Institutional Neurocognitive Discovery Study" (MINDS) in Adult Congenital Heart Disease (ACHD). The MINDS-ACHD" study will recruit 500 complex CHD patients between18-30 years old. The investigators propose to q...
What is the current status of trial NCT05270356?
This trial is currently completed. The enrollment target is 195 participants. The study started on 2021-05-27. Estimated completion is 2025-05-31.
What interventions are being tested in trial NCT05270356?
The interventions under investigation include: MRI (OTHER).
Who is sponsoring clinical trial NCT05270356?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04276922 · 195 participants · NA
Creative Arts Program to Reduce Burnout in Healthcare Professionals
- NCT04829357 · 195 participants
Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System
- NCT05054738 · 195 participants · NA
CRP and S&A for Inpatient Veterans
- NCT05561595 · 195 participants · NA
Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI